TY - JOUR
T1 - Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care
AU - Thomas, Michael L.
AU - Bismark, Andrew W.
AU - Joshi, Yash B.
AU - Tarasenko, Melissa
AU - Treichler, Emily B.H.
AU - Hochberger, William C.
AU - Zhang, Wen
AU - Nungaray, John
AU - Sprock, Joyce
AU - Cardoso, Lauren
AU - Tiernan, Kristine
AU - Attarha, Mouna
AU - Braff, David L.
AU - Vinogradov, Sophia
AU - Swerdlow, Neal
AU - Light, Gregory A.
N1 - Funding Information:
Research reported in this publication was supported by the Sidney R. Baer, Jr. Foundation (25293), the Brain and Behavior Research Foundation, VISN-22 Mental Illness Research Education and Clinical Center (MIRECC), and National Institute of Mental Health of the National Institutes of Health (K23 MH102420).
Publisher Copyright:
© 2018
PY - 2018/12
Y1 - 2018/12
N2 - Computerized targeted cognitive training (TCT) of auditory processing has been shown to improve verbal learning in several clinical trials of schizophrenia outpatients. Less is known, however, about the effectiveness of this promising intervention in more chronic, treatment-refractory patients who are treated in non-academic settings. This study aimed to determine whether TCT improves auditory processing, verbal learning, and clinical symptoms in SZ patients mandated to receive care at a locked residential rehabilitation center. Secondarily, potential factors that moderate TCT's effectiveness including age, symptom severity, antipsychotic medication load, and duration of illness were examined. Schizophrenia patients were randomized to treatment as usual (TAU; n = 22) or TAU augmented with TCT (TAU + TCT; n = 24). Outcomes included a measure of auditory perception (Word-In-Noise test, WIN), verbal learning domain scores from the MATRICS Consensus Cognitive Battery (MCCB), and clinical symptoms (Scale for the Assessment of Positive Symptoms, SAPS; Scale for the Assessment of Negative Symptoms, SANS). TCT produced significant improvements in auditory perception (d = 0.67) and verbal learning (d = 0.65); exploratory analyses revealed a statistically significant reduction in auditory hallucinations (d = −0.64). TCT's effects were only weakly, and mostly non-significantly, moderated by age, clinical symptoms, medication, and illness duration. These findings indicate that even highly symptomatic, functionally disabled patients with chronic illness benefit from this emerging treatment. Ongoing studies will examine the predictive utility of neurophysiological biomarkers and other characteristics assessed at baseline.
AB - Computerized targeted cognitive training (TCT) of auditory processing has been shown to improve verbal learning in several clinical trials of schizophrenia outpatients. Less is known, however, about the effectiveness of this promising intervention in more chronic, treatment-refractory patients who are treated in non-academic settings. This study aimed to determine whether TCT improves auditory processing, verbal learning, and clinical symptoms in SZ patients mandated to receive care at a locked residential rehabilitation center. Secondarily, potential factors that moderate TCT's effectiveness including age, symptom severity, antipsychotic medication load, and duration of illness were examined. Schizophrenia patients were randomized to treatment as usual (TAU; n = 22) or TAU augmented with TCT (TAU + TCT; n = 24). Outcomes included a measure of auditory perception (Word-In-Noise test, WIN), verbal learning domain scores from the MATRICS Consensus Cognitive Battery (MCCB), and clinical symptoms (Scale for the Assessment of Positive Symptoms, SAPS; Scale for the Assessment of Negative Symptoms, SANS). TCT produced significant improvements in auditory perception (d = 0.67) and verbal learning (d = 0.65); exploratory analyses revealed a statistically significant reduction in auditory hallucinations (d = −0.64). TCT's effects were only weakly, and mostly non-significantly, moderated by age, clinical symptoms, medication, and illness duration. These findings indicate that even highly symptomatic, functionally disabled patients with chronic illness benefit from this emerging treatment. Ongoing studies will examine the predictive utility of neurophysiological biomarkers and other characteristics assessed at baseline.
KW - Chronic psychosis
KW - Cognitive remediation
KW - Effectiveness
KW - Schizophrenia
KW - Targeted cognitive training
UR - http://www.scopus.com/inward/record.url?scp=85050359704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050359704&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2018.07.025
DO - 10.1016/j.schres.2018.07.025
M3 - Article
C2 - 30055883
AN - SCOPUS:85050359704
SN - 0920-9964
VL - 202
SP - 378
EP - 384
JO - Schizophrenia Research
JF - Schizophrenia Research
ER -